Company Monitoring Page for Novo-Nordisk

latest headlines for company on cafepharma

Novo pulls blockbuster diabetes med Victoza off the Type 1 track
Fierce Pharma Marketing
Wed, 08/26/15 - 10:41 am
Tags:
Novo Nordisk, Victoza, diabetes, type 1 diabetes
Lilly, Sanofi, Novo among many pharma players to throw off big price gains in H1
Fierce Pharma
Sat, 08/22/15 - 08:48 am
Tags:
Sanofi, Novo Nordisk, Eli Lilly, AstraZeneca, GSK, JNJ, stock prices
Will pricey new drug classes take the wind out of diabetes launches?
Fierce Pharma Marketing
Wed, 08/19/15 - 10:01 am
Tags:
diabetes, Novo Nordisk, Eli Lilly, Boehringer Ingelheim, Sanofi
Novo Nordisk ties the R&D knot with Genmab, and they're not focused on cancer
Fierce Biotech
Fri, 08/14/15 - 11:20 am
Tags:
Genmab, Novo Nordisk, R&D
Biggest Insulin Maker May Build Diabetes Drug Plant in U.S.
Bloomberg
Fri, 08/14/15 - 09:18 am
Tags:
Novo Nordisk, drug manufacturing, diabetes, insulin
Novo reports stronger-than-expected Q2, raises full-year forecast
BioPharma Dive
Fri, 08/7/15 - 05:34 pm
Tags:
Novo Nordisk, earnings
Novo Nordisk says any tussle with Sanofi's Toujeo will come down to formulary access
Medical Marketing and Media
Fri, 08/7/15 - 08:43 am
Tags:
Sanofi, Novo Nordisk, Toujeo, formulary, Tresiba, insulin, diabetes
Drugmakers like Gilead, Mylan and Novo--not Big Pharma--are job creators
Fierce Pharma
Wed, 07/22/15 - 09:40 pm
Tags:
Big Pharma, Gilead Sciences, Mylan Labs, Novo Nordisk, Merck, Bayer
Top 10 pharma companies in social media
Fierce Pharma Marketing
Mon, 07/20/15 - 09:12 am
Tags:
social media, Boehringer Ingelheim, Bayer, Novartis, JNJ, Merck, Abbott Labs, GSK, Roche, Novo Nordisk, AstraZeneca
Novo Nordisk says Flexpro PenMate gets FDA approval
Yahoo/Reuters
Thu, 07/16/15 - 10:30 pm
Tags:
Flexpro PenMate, Novo Nordisk, FDA, Norditropin, devices
Novo Nordisk looks past blockbuster Victoza with PhIII success for weekly GLP-1 med
Fierce Pharma Marketing
Tue, 07/14/15 - 10:41 am
Tags:
Novo Nordisk, diabetes, Victoza, semaglutide, GLP-1 agonist
Novo Nordisk's new GLP-1 diabetes drug hits goal in trial
Yahoo/Reuters
Sat, 07/11/15 - 10:25 am
Tags:
Novo Nordisk, GLP-1 agonist, diabetes, semaglutide
Novo Nordisk backs out of a diabetes deal with Zosano
Fierce Biotech
Mon, 07/6/15 - 08:39 pm
Tags:
Novo Nordisk, Zosano, diabetes, drug delivery
Novo to halt Tresiba sales in Germany over pricing conflict
BioPharma Dive
Thu, 07/2/15 - 11:16 am
Tags:
Novo Nordisk, Tresiba, diabetes, Germany, drug pricing
Report: It pays big to focus on diabetes drugs
BioPharma Dive
Thu, 06/25/15 - 11:47 am
Tags:
diabetes, Sanofi, Merck, Novo Nordisk
Expect Novo Nordisk To Commit To Their Late-Stage Diabetes Pill Development Soon
Seeking Alpha
Thu, 06/18/15 - 09:18 am
Tags:
Novo Nordisk, GLP-1 agonist, diabetes
AdverseEvents: Diabetes drug analysis flags heart failure, pancreatitis reports
Fierce Pharma
Tue, 06/16/15 - 12:08 pm
Tags:
diabetes, side effects, heart failure, pancreatitis, Nesina, Takeda, Onglyza, AstraZeneca, Farixga, Byetta, Victoza, Januvia, Merck, Novo Nordisk
Novo Nordisk type 2 diabetes combo drug tops Sanofi's Lantus -study
Yahoo/Reuters
Sun, 06/7/15 - 10:03 am
Tags:
Novo Nordisk, type 2 diabetes, Sanofi, IDegLira, Lantus
Novo Nordisk executive fuels firm's new obesity fight
Medical Marketing and Media
Tue, 05/26/15 - 10:46 am
Tags:
Novo Nordisk, obesity, Saxenda, Jesper Høiland
Novo Nordisk rejects Baxter patent claim over Novoeight
Yahoo/Reuters
Wed, 05/20/15 - 06:19 pm
Tags:
Novo Nordisk, Baxter International, NovoEight

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.